Filing Details

Accession Number:
0001104659-22-010336
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-01 16:30:39
Reporting Period:
2022-01-28
Accepted Time:
2022-02-01 16:30:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1633070 Axcella Health Inc. AXLA Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1774662 William Hinshaw C/O Axcella Health Inc.
840 Memorial Drive
Cambridge MA 02139
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-28 50,000 $0.00 50,000 No 4 M Direct
Common Stock Disposition 2022-01-31 16,590 $1.65 33,410 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-01-28 50,000 $0.00 50,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
  2. Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.61 to $1.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  4. The restricted stock units vested in full on January 28, 2022.